ABUSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Arbutus Biopharma Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$4.23+0.01 (+0.24%)
Close on Oct 19, 2026
- Market cap
- $835.30M
- P/E (TTM)
- 5.4
- Dividend yield
- –
SEC filings
40 of Arbutus Biopharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 20, 2026 | Oct 22, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2026 | Aug 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2026 | Jul 16, 2026 | SEC EDGAR |
| Current report | 8-K | May 26, 2026 | May 27, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2026 | Apr 15, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 26, 2026 | Apr 14, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 20, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 2, 2026 | Feb 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2026 | Jan 16, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2025 | Oct 7, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | May 21, 2025 | May 23, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2025 | Apr 23, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 21, 2025 | Apr 4, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 28, 2025 | Apr 3, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2025 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 15, 2024 | Nov 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2024 | Oct 15, 2024 | SEC EDGAR |